The sweeping legislation promises $500 million dollars for the states to fight the opioid epidemic, an important issue going into the midterms for both parties, and is similar to what the House produced. Other news on opioids looks at efforts to stem foreign fentanyl supplies, Colorado's lawsuit against Purdue, Maryland's misconduct charges against Insys Therapeutics, Endo's attempt to limit lawsuits, a decision by Blue Cross to stop paying for OxyContin, and more.
from Kaiser Health News https://ift.tt/2MWhbE8
September 07, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Colorado Unveils Public Option Reimbursement Rates That Officials Say Will Help Hospitals Remain ProfitableThe Colorado Health Insurance Option formula's base rate is 155% of Medicare rates, but hospitals' individual rates would vary based on hospital type. Hospitals are still wary about the option, though. It seems likely hospita… Read More
First Edition: February 26, 2020Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/390NnND … Read More
Trusting Injection Drug Users With IV Antibiotics At Home: It Can WorkTwo mornings a week, Arthur Jackson clears space on half of his cream-colored sofa. He sets out a few rolls of tape and some gauze, then waits for a knock on his front door. “This is Brenda’s desk,” Jackson said with a chuckl… Read More
As The Coronavirus Spreads, Americans Lose Ground Against Other Health ThreatsFor much of the 20th century, medical progress seemed limitless. Antibiotics revolutionized the care of infections. Vaccines turned deadly childhood diseases into distant memories. Americans lived longer, healthier lives than… Read More
Democrats Sharpen Health Care Attacks As Primaries Heat UpThe ideal began to get real on Tuesday, as seven of the top contenders for the Democratic presidential nomination sparred over the price tag on health care reform and even revealed similarities on issues like marijuana legali… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment